The Food and Drug Administration has approved omalizumab – the brand Xolair – to help those with one or more… Read more »
Tag: Dr. Jay Lieberman
Neffy CEO: Why FDA Rejection of Epi Nasal Spray Was a Shocker
In the fall of 2023, ARS Pharma’s epinephrine nasal spray seemed like a sure bet to win Food and Drug… Read more »